SCHEMBL12874334

SCHEMBL12874334

CC(=O)c1cn2c3c(c(NCCNc4ccccn4)c(F)c(N)c3c1=O)OCC1(CCC1)C2

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094712 0.94 GSK3B (0.81) GSK3B
SCHEMBL8095662 0.91 GSK3B (0.83) GSK3B
SCHEMBL12874328 0.89 GSK3B (0.88) GSK3B
SCHEMBL8234143 0.85 GSK3B (1.00) GSK3B
SCHEMBL12130689 0.85 GSK3B (0.67) GSK3B
SCHEMBL1186113 0.83 GSK3B (1.00) GSK3B
SCHEMBL8097673 0.82 GSK3B (0.81) GSK3B
SCHEMBL1186244 0.81 GSK3B (1.00) GSK3B
SCHEMBL1345001 0.80 GSK3B (1.00) GSK3B
SCHEMBL1344942 0.80 GSK3B (1.00) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110034436-A1 SPIROCYCLIC AMINOQUINOLNES AS GSK-3 INHIBITORS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034436-A1 SPIROCYCLIC AMINOQUINOLNES AS GSK-3 INHIBITORS GSK3A, GSK3B, GSKIP GSK3B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.